Alfred Joseph Eusini, CRNA - Medicare Certified Registered Nurse Anesthetist (crna) in Livingston, NJ

Alfred Joseph Eusini, CRNA is a medicare enrolled "Nurse Anesthetist, Certified Registered" in Livingston, New Jersey. He graduated from nursing school in 2019 and has 5 years of diverse experience with area of expertise as Certified Registered Nurse Anesthetist (crna). He is a member of the group practice Rwjbh Observation Associates Llc and his current practice location is 94 Old Short Hills Rd, Livingston, New Jersey. You can reach out to his office (for appointments etc.) via phone at (973) 322-5000.

Alfred Joseph Eusini is licensed to practice in New Jersey (license number 26NJ01017000) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1902441363.

Contact Information

Alfred Joseph Eusini, CRNA
94 Old Short Hills Rd,
Livingston, NJ 07039-5672
(973) 322-5000
Not Available



Provider's Profile

Full NameAlfred Joseph Eusini
GenderMale
SpecialityCertified Registered Nurse Anesthetist (crna)
Experience5 Years
Location94 Old Short Hills Rd, Livingston, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Alfred Joseph Eusini graduated from nursing school in 2019
  NPI Data:
  • NPI Number: 1902441363
  • Provider Enumeration Date: 11/08/2019
  • Last Update Date: 03/07/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 0840628707
  • Enrollment ID: I20200309000586

Medical Identifiers

Medical identifiers for Alfred Joseph Eusini such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1902441363NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
163W00000XRegistered Nurse 615739-1 (New York)Secondary
367500000XNurse Anesthetist, Certified Registered 26NJ01017000 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Saint Barnabas Medical CenterLivingston, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Rwjbh Observation Associates Llc5193137503598

News Archive

U.S to face potential outbreak of hyperinflation by 2015

The National Inflation Association - http://inflation.us - today issued a warning to all Americans of a potential outbreak of hyperinflation in the U.S. by year 2015 caused primarily by the healthcare bill and rising interest payments on our national debt.

ISTA Pharmaceuticals first-quarter net revenues up 39%

ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.

New report reinforces the evidence for exceptional returns from health research

A Lateral Economic's Report "The Economic Value of Australia's Investment in Health and Medical Research," provides an up to date analysis of the pay-back of the significant investment by the Australian Government and business community in HMR in Australia.

House bill may target drugmakers' advertising tax breaks

Rep. Charles Rangel, D-N.Y., says the House Ways and Means Committee may seek to raise money for health reform by imposing a $37 billion tax on drugmaker's advertisements, Bloomberg reports: "As lawmakers seek ways to pay for a health-care overhaul, 'one thing that's not off the table is you can pick up $37 billion knocking out the deduction for advertising' for prescription drugs,'" Rangel said. The idea is among several proposals by Democratic legislators to raise reform money (Donmoyer, 6/16).

IDC grants MedImmune global rights to GLA adjuvant

Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has entered into a license and development agreement with MedImmune for the use and commercialization of IDC's proprietary Glucopyranosyl Lipid Adjuvant (GLA) as a component in vaccines for select infectious diseases.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Alfred Joseph Eusini allows following entities to bill medicare on his behalf.
Entity NameAmerican Anesthesiology Of New Jersey Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1386654036
PECOS PAC ID: 0042112500
Enrollment ID: O20040123001039

News Archive

U.S to face potential outbreak of hyperinflation by 2015

The National Inflation Association - http://inflation.us - today issued a warning to all Americans of a potential outbreak of hyperinflation in the U.S. by year 2015 caused primarily by the healthcare bill and rising interest payments on our national debt.

ISTA Pharmaceuticals first-quarter net revenues up 39%

ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.

New report reinforces the evidence for exceptional returns from health research

A Lateral Economic's Report "The Economic Value of Australia's Investment in Health and Medical Research," provides an up to date analysis of the pay-back of the significant investment by the Australian Government and business community in HMR in Australia.

House bill may target drugmakers' advertising tax breaks

Rep. Charles Rangel, D-N.Y., says the House Ways and Means Committee may seek to raise money for health reform by imposing a $37 billion tax on drugmaker's advertisements, Bloomberg reports: "As lawmakers seek ways to pay for a health-care overhaul, 'one thing that's not off the table is you can pick up $37 billion knocking out the deduction for advertising' for prescription drugs,'" Rangel said. The idea is among several proposals by Democratic legislators to raise reform money (Donmoyer, 6/16).

IDC grants MedImmune global rights to GLA adjuvant

Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has entered into a license and development agreement with MedImmune for the use and commercialization of IDC's proprietary Glucopyranosyl Lipid Adjuvant (GLA) as a component in vaccines for select infectious diseases.

Read more Medical News

› Verified 8 days ago

Entity NameNorth American Partners In Anesthesia Of New Jersey Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548433048
PECOS PAC ID: 5890867410
Enrollment ID: O20080626000318

News Archive

U.S to face potential outbreak of hyperinflation by 2015

The National Inflation Association - http://inflation.us - today issued a warning to all Americans of a potential outbreak of hyperinflation in the U.S. by year 2015 caused primarily by the healthcare bill and rising interest payments on our national debt.

ISTA Pharmaceuticals first-quarter net revenues up 39%

ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.

New report reinforces the evidence for exceptional returns from health research

A Lateral Economic's Report "The Economic Value of Australia's Investment in Health and Medical Research," provides an up to date analysis of the pay-back of the significant investment by the Australian Government and business community in HMR in Australia.

House bill may target drugmakers' advertising tax breaks

Rep. Charles Rangel, D-N.Y., says the House Ways and Means Committee may seek to raise money for health reform by imposing a $37 billion tax on drugmaker's advertisements, Bloomberg reports: "As lawmakers seek ways to pay for a health-care overhaul, 'one thing that's not off the table is you can pick up $37 billion knocking out the deduction for advertising' for prescription drugs,'" Rangel said. The idea is among several proposals by Democratic legislators to raise reform money (Donmoyer, 6/16).

IDC grants MedImmune global rights to GLA adjuvant

Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has entered into a license and development agreement with MedImmune for the use and commercialization of IDC's proprietary Glucopyranosyl Lipid Adjuvant (GLA) as a component in vaccines for select infectious diseases.

Read more Medical News

› Verified 8 days ago

Entity NameRwjbh Observation Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1760095806
PECOS PAC ID: 5193137503
Enrollment ID: O20201209000008

News Archive

U.S to face potential outbreak of hyperinflation by 2015

The National Inflation Association - http://inflation.us - today issued a warning to all Americans of a potential outbreak of hyperinflation in the U.S. by year 2015 caused primarily by the healthcare bill and rising interest payments on our national debt.

ISTA Pharmaceuticals first-quarter net revenues up 39%

ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.

New report reinforces the evidence for exceptional returns from health research

A Lateral Economic's Report "The Economic Value of Australia's Investment in Health and Medical Research," provides an up to date analysis of the pay-back of the significant investment by the Australian Government and business community in HMR in Australia.

House bill may target drugmakers' advertising tax breaks

Rep. Charles Rangel, D-N.Y., says the House Ways and Means Committee may seek to raise money for health reform by imposing a $37 billion tax on drugmaker's advertisements, Bloomberg reports: "As lawmakers seek ways to pay for a health-care overhaul, 'one thing that's not off the table is you can pick up $37 billion knocking out the deduction for advertising' for prescription drugs,'" Rangel said. The idea is among several proposals by Democratic legislators to raise reform money (Donmoyer, 6/16).

IDC grants MedImmune global rights to GLA adjuvant

Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has entered into a license and development agreement with MedImmune for the use and commercialization of IDC's proprietary Glucopyranosyl Lipid Adjuvant (GLA) as a component in vaccines for select infectious diseases.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alfred Joseph Eusini is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Alfred Joseph Eusini, CRNA
11 Pine St Apt 417,
Montclair, NJ 07042-4381

Ph: (646) 678-0776
Alfred Joseph Eusini, CRNA
94 Old Short Hills Rd,
Livingston, NJ 07039-5672

Ph: (973) 322-5000

News Archive

U.S to face potential outbreak of hyperinflation by 2015

The National Inflation Association - http://inflation.us - today issued a warning to all Americans of a potential outbreak of hyperinflation in the U.S. by year 2015 caused primarily by the healthcare bill and rising interest payments on our national debt.

ISTA Pharmaceuticals first-quarter net revenues up 39%

ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.

New report reinforces the evidence for exceptional returns from health research

A Lateral Economic's Report "The Economic Value of Australia's Investment in Health and Medical Research," provides an up to date analysis of the pay-back of the significant investment by the Australian Government and business community in HMR in Australia.

House bill may target drugmakers' advertising tax breaks

Rep. Charles Rangel, D-N.Y., says the House Ways and Means Committee may seek to raise money for health reform by imposing a $37 billion tax on drugmaker's advertisements, Bloomberg reports: "As lawmakers seek ways to pay for a health-care overhaul, 'one thing that's not off the table is you can pick up $37 billion knocking out the deduction for advertising' for prescription drugs,'" Rangel said. The idea is among several proposals by Democratic legislators to raise reform money (Donmoyer, 6/16).

IDC grants MedImmune global rights to GLA adjuvant

Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has entered into a license and development agreement with MedImmune for the use and commercialization of IDC's proprietary Glucopyranosyl Lipid Adjuvant (GLA) as a component in vaccines for select infectious diseases.

Read more News

› Verified 8 days ago


Nurse Anesthetist, Certified Registered Nurses in Livingston, NJ

Christina M Starker, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039
Phone: 973-322-5000    Fax: 973-660-9779
Boris G Kouanang, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 94 Old Short Hills Rd Ste 1, Livingston, NJ 07039
Phone: 973-322-5000    
John Tomasello, CRNA, APN
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 94 Old Short Hills Rd Ste 1, Livingston, NJ 07039
Phone: 973-322-5000    
Ms. Randi Terry Davis, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 200 S Orange Ave, Livingston, NJ 07039
Phone: 973-577-4056    
Dr. Stephen Patrick Pilot, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039
Phone: 973-322-5000    
Cori Kutzin, APN, CRNA
Nurse Anesthetist - CR
Medicare: Medicare Enrolled
Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039
Phone: 973-322-5000    
Mr. Mcalistair James, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039
Phone: 973-322-5000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.